3wVentures
VC Fund
Herisau, Switzerland
3wVentures is a VC fund in Herisau focused on Software and Health Care. 3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.
- Total investments:
- 42
- Last investment:
- Lead investor:
- 2%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries 3wVentures invests in
SoftwareHealth CareSearch EngineInformation TechnologyMedical
Stages 3wVentures invests in
SeedAngelSeries ASeries BSeries C
Countries 3wVentures invests in
SwitzerlandSpainAustriaGermanyUnited States
Round sizes
Seed $50k–$3.5MAngel $583k–$2.1MSeries A $1.2M–$8M
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $50k–$3.5M
- Angel
- $583k–$2.1M
- Series A
- $1.2M–$8M
Investment Focus
Industry
- Software 12 (29%)
- Health Care 8 (19%)
- Search Engine 5 (12%)
- Information Technology 5 (12%)
- Medical 4 (10%)
Stage
- Seed 20 (48%)
- Angel 11 (26%)
- Series A 8 (19%)
- Series B 1 (2%)
- Series C 1 (2%)
Country
- Switzerland 34 (81%)
- Spain 1 (2%)
- Austria 1 (2%)
- Germany 1 (2%)
- United States 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Yves Latour
Co-Founder
|
Co-Founder | Total investments: 4 | Find email | |
Arvin Zuberbuehler
Co-Founding Partner
|
Co-Founding Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from: | $20.9M / Series C / Mar 28, 2018 | ||
| Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management. | $3.5M / Seed / Feb 14, 2018 | ||
| GUURU is a Customer Interaction Solution that combines AI with the human experience of product users. We enable brands to provide efficient First Contact Resolution with a single platform leveraging their most proficient and dedicated customers. Contact us to find out more. | $856.8K / Seed / Jan 26, 2018 | ||
| PICSTARS was founded in 2014 and is one of the top 10 tech startups in Switzerland (Venture Leader 2016). Their mission is to digitize the sponsorship of brand ambassadors with a focus on athletes. With PICSTARS, Brands find suitable talents in Sport & Lifestyle as brand ambassadors who use their own social media channels to communicate brandphoto / video and hashtag campaigns. In the PICSTARS cockpit, companies can create campaigns directly and measure success. | $2.1M / Series A / Jan 23, 2018 | ||
| Insolight is an energy company that develops and manufactures solar panels. Insolight has developed solar modules with record efficiency 29 percent to reduce residential solar electricity costs below 0.1 $/kWh. Its innovative optical technology combines high efficiency with the ease of mounting of a standard flat panel. Insolight hassuccessfully passed third-party validation at Fraunhofer ISE (36% efficiency on Lab prototype) and at the UPM in Madrid (29% on pre-industrial module). Its business model is to develop the IP, control wholesale distribution and outsource manufacturing.The company was founded in 2015. | $2.4M / Seed / Jan 22, 2018 | ||
| Firstbird, the digital employee referral program, connects people with jobs and companies worldwide with suitable candidates. With Firstbird, employees become brand ambassadors, and referrals become a company’s most successful recruiting channel. Firstbird integrates easily with your ATS to make your life easier. | $2.5M / Seed / Jan 16, 2018 | ||
| BYHOURS is the first international platform that allows you to book stays of 3, 6 and 24 hours in more than 4000 hotels of the best chains around the world. It is available in more than 25 countries. Bringing "pay per use" to hotels: users choose the time they want to check in and check out of their room 24 hours a day and pay only forthe time they need.BYHOURS has introduced a new and disruptive business model in travel industry, about microstays and pay-per-use, based in flexibility, which also allow hotels to increase their income, as well as monetize and optimize their resources. Founded in March of 2012 in Barcelona, the company has experienced rapid growth, working with more than 4500 hotels in Europe, Latin America and some key cities in the Middle East. After partnering with major international top hotel chains, has also evolved to a travel-tech company offering B2B and B2B2C services via SAAS, joining forces with international companies such as SABRE (the leading travel agencies software), RAPPI (the multi-vertical super-app leader in Latin America) or AXA Insurances. | $3.5M / Series A / Dec 15, 2017 | ||
| Astrocast SA is the most advanced SatIoT Service for customers looking to track, monitor, manage, and communicate with assets in remote regions of the world. With the world's most innovative nanostatelliite network, Astrocast delivers a complete end-to-end, direct-to-orbit service that, state-of-the-art communication modules, and enterpriseclass services. In partnership with Airbus, CEA/LETI, the European Space Agency, and Thuraya, Astrocast has developed Astronode S, a cutting-edge terminal featuring low profile L-band antenna, ultra-low power consumption, and a small form factor. Astrocast enables companies like Marine Instruments and Wildlife Computers to expand their IoT strategies. | $4.3M / Seed / Aug 25, 2017 | ||
| DBS System SA, producer of HemaXis™ blood collection devices, is a medtech company located in the Swiss Health Valley providing advanced technology to collect and prepare blood samples in a less invasive, easier, cheaper, safer manner with precision and industry standard processes.They produce devices with patented microfluidic technology capableof plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis.DBS System is “Unleashing Labs to Stay Well”. The innovative HemaXis platform was developed to combine the power of labs to test and monitor health with people’s desire to stay well.HemaXis will help democratize blood collection and support “big data” initiatives important to the development of effective and efficient personalized medicine. | $2.5M / Series A / May 04, 2017 | ||
| Beekeeper is a mobile-first communication platform that reaches every shift, location, and language through real-time messaging and targeted streams. Managers keep frontline teams productive and turnover low by automating workflows while leveraging an analytics dashboard to measure engagement. Beekeeper integrates with operational systems, makingthem accessible in one central portal. | $8M / Series A / Mar 21, 2017 | ||
| See all 42 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
SaaS Investors
114,773 investors
Enterprise Investors
90,001 investors
Software Investors
56,294 investors
Health Care Investors
47,147 investors
Medical Investors
20,530 investors
SaaS VC Funds
70,511 investors
Enterprise VC Funds
57,667 investors
Software VC Funds
35,944 investors
Health Care VC Funds
35,356 investors
FAQ
What does 3wVentures invest in?
3wVentures invests primarily in Software, Health Care and Search Engine startups, most often at Seed and Angel stage. Most of the 42 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is 3wVentures's check size?
3wVentures typically joins rounds of $50k–$3.5M at Seed, $583k–$2.1M at Angel and $1.2M–$8M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds 3wVentures participates in.
How do I contact 3wVentures?
Public channels for 3wVentures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at 3wVentures?
The team at 3wVentures includes Yves Latour (Co-Founder) and Arvin Zuberbuehler (Co-Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
